08:19:33 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande


2025-02-21 Bokslutskommuniké 2024
2024-10-25 Kvartalsrapport 2024-Q3
2024-08-23 Kvartalsrapport 2024-Q2
2024-06-03 X-dag ordinarie utdelning MEDF 0.00 SEK
2024-05-31 Årsstämma 2024
2024-05-27 Kvartalsrapport 2024-Q1
2024-02-29 Bokslutskommuniké 2023
2023-12-22 Extra Bolagsstämma 2023
2023-10-27 Kvartalsrapport 2023-Q3
2023-08-25 Kvartalsrapport 2023-Q2
2023-06-05 X-dag ordinarie utdelning MEDF 0.00 SEK
2023-06-02 Årsstämma 2023
2023-04-21 Kvartalsrapport 2023-Q1
2023-02-24 Bokslutskommuniké 2022
2022-10-28 Kvartalsrapport 2022-Q3
2022-08-26 Kvartalsrapport 2022-Q2
2022-06-07 X-dag ordinarie utdelning MEDF 0.00 SEK
2022-06-03 Årsstämma 2022
2022-04-22 Kvartalsrapport 2022-Q1
2022-02-25 Bokslutskommuniké 2021
2021-10-22 Kvartalsrapport 2021-Q3
2021-08-20 Kvartalsrapport 2021-Q2
2021-06-07 X-dag ordinarie utdelning MEDF 0.00 SEK
2021-06-04 Årsstämma 2021
2021-04-16 Kvartalsrapport 2021-Q1
2021-02-19 Bokslutskommuniké 2020
2020-11-10 Extra Bolagsstämma 2020
2020-11-04 Kvartalsrapport 2020-Q3
2020-08-26 Kvartalsrapport 2020-Q2
2020-06-08 X-dag ordinarie utdelning MEDF 0.00 SEK
2020-06-05 Årsstämma 2020
2020-04-29 Kvartalsrapport 2020-Q1
2020-02-20 Bokslutskommuniké 2019
2019-11-13 Extra Bolagsstämma 2019
2019-11-06 Kvartalsrapport 2019-Q3
2019-08-30 Kvartalsrapport 2019-Q2
2019-06-11 Årsstämma 2019
2019-06-07 X-dag ordinarie utdelning MEDF 0.00 SEK
2019-05-22 Kvartalsrapport 2019-Q1
2019-02-22 Bokslutskommuniké 2018
2018-11-02 Kvartalsrapport 2018-Q3
2018-08-31 Kvartalsrapport 2018-Q2
2018-06-08 X-dag ordinarie utdelning MEDF 0.00 SEK
2018-06-07 Årsstämma 2018
2018-05-09 Kvartalsrapport 2018-Q1
2018-02-22 Bokslutskommuniké 2017
2017-11-02 Kvartalsrapport 2017-Q3
2017-08-31 Kvartalsrapport 2017-Q2
2017-06-16 X-dag ordinarie utdelning MEDF 0.00 SEK
2017-06-15 Årsstämma 2017
2017-05-15 Kvartalsrapport 2017-Q1
2017-02-22 Bokslutskommuniké 2016
2016-11-02 Kvartalsrapport 2016-Q3
2016-08-31 Kvartalsrapport 2016-Q2
2016-06-08 X-dag ordinarie utdelning MEDF 0.00 SEK
2016-06-07 Extra Bolagsstämma 2016
2016-06-07 Årsstämma 2016
2016-04-27 Kvartalsrapport 2016-Q1
2016-02-26 Bokslutskommuniké 2015
2015-11-06 Kvartalsrapport 2015-Q3
2015-08-31 Kvartalsrapport 2015-Q2
2015-06-09 X-dag ordinarie utdelning MEDF 0.00 SEK
2015-06-08 Årsstämma 2015
2015-05-08 Kvartalsrapport 2015-Q1
2015-02-24 Bokslutskommuniké 2014
2015-01-27 Extra Bolagsstämma 2014
2014-11-04 Kvartalsrapport 2014-Q3
2014-09-02 Kvartalsrapport 2014-Q2
2014-06-03 X-dag ordinarie utdelning MEDF 0.00 SEK
2014-06-02 Årsstämma 2014
2014-05-06 Kvartalsrapport 2014-Q1
2014-02-18 Bokslutskommuniké 2013
2013-11-19 Kvartalsrapport 2013-Q3
2013-11-18 Extra Bolagsstämma 2013
2013-08-28 Kvartalsrapport 2013-Q2
2013-06-20 X-dag ordinarie utdelning MEDF 0.00 SEK
2013-06-19 Årsstämma 2013
2013-04-19 Kvartalsrapport 2013-Q1
2013-02-18 Bokslutskommuniké 2012
2012-10-08 Kvartalsrapport 2012-Q3
2012-08-13 Kvartalsrapport 2012-Q2
2012-05-14 Kvartalsrapport 2012-Q1


Medfield Diagnostics utvecklar diagnosinstrument som används bland aktörer inom sjukvård. Instrumenten används vid urskiljandet av strokefall. Utöver används bolagets egenutvecklade teknologi för diagnostisering av traumatiska skallskador. Tekniken baseras på mikrovågsbaserade system som via antenner analyserar och registrerar sammansättningen av vävnaden. Bolaget etablerades under 2005 och har sitt huvudkontor i Göteborg.
2024-02-29 00:36:11

Medfield Diagnostics meddelar att New South Wales Ambulance Service rapporterar i en mediarelease om goda erfarenheter från användningen av MD100 Strokefinder i en ambulansstudie.

John Hunter Hospital, New South Wales Ambulance Service och Stroke Alliance genomför en ambulansstudie med MD100 Strokefinder. Paramedic Immediate Care Units (PICU) från New South Wales Ambulance Service har med hjälp av MD100 Strokefinder bedömt cirka 100 patienter i samband med larm om en misstänkt stroke.

Media release:" NSW Ambulance first in the world to trial new stroke care technology" Länk : NSW Ambulance first in the world to trial new stroke care technology - (https://www.ambulance.nsw.gov.au/news/news-items/nsw-ambulance-first-in-the-world-to-trial-new-stroke-care-technology)

A world-first collaborative trial will see cutting-edge technology used by NSW Ambulance as part of the rapid assessment and triage of stroke patients as they are transported to hospital.

A revolutionary new brain scanner, the Medfield Diagnostics Strokefinder MD100 helmet, is currently being piloted by NSW Ambulance paramedics in the Hunter region, the first time the Strokefinder helmet technology is being utilised on the frontline and outside of hospital.

Minister for Regional Health Ryan Park said this innovative trial could enable even faster stroke diagnosis and treatment, meaning more patients stand to benefit from timely stroke interventions in the vital `golden hour'.

"Stroke is a time critical emergency and is one of Australia's biggest killers, so the earlier our paramedics and neurologists can assess and treat patients, the better the outcome," Mr Park said.

"I am really proud our NSW Ambulance paramedics are the first in the world to use this device in the pre-hospital setting.

"This is a wonderful example of some of the truly collaborative projects taking place across the health system right now, where cutting-edge technology and our highly skilled hospital clinicians and frontline paramedics work together."

NSW Ambulance Commissioner Dr Dominic Morgan said the technology is fast to operate and performs multiple brain measurements in 60 seconds.

"This exciting study brings together NSW Ambulance intensive care paramedics and John Hunter Hospital neurologists, and the Hunter Medical Research Institute, to evaluate the feasibility of the Strokefinder MD100 helmet in pre-hospital care," Dr Morgan said. "When combined with an innovative telehealth app, our paramedics on the ground are able to consult with the neurology team in the hospital to optimise the care and overall outcome for the stroke patient."

Acute Stroke Services Neurologist at John Hunter Hospital and study lead, neurologist Professor Chris Levi, said clinicians and researchers will work together closely to evaluate and refine how the stroke detection system and telehealth app can optimise frontline care.

"When a stroke occurs, rapid and accurate diagnosis is vital to speed up the delivery of treatment interventions and improve clinical outcomes for the patient," Professor Levi said.

Preliminary data from the trial shows almost all patients were scanned within an hour of the Triple Zero call being made.

Minister for Medical Research David Harris said these results of the trial have been remarkable considering less than five per cent of stroke patients in Australia undergo a hospital CT scan within an hour of suffering a stroke.

"Although still in the research phase, this innovation allows paramedics to rapidly scan the brain, hopefully within what's known as the `golden hour' after a stroke occurs which is when we can optimise treatment outcomes for the patient," Mr Harris said.Jack Di Tommaso, a 27-year-old gym owner and personal trainer from Newcastle, recently completed a marathon when an ischaemic stroke gave him and his family the shock of their lives. Jack didn't know what to make of his sudden symptoms, which included slurred speech and reduced consciousness.

Thanks to this trial, the Strokefinder MD100 scan was performed on Jack within the `golden hour' after suffering a stroke and his clinical information was captured in the telehealth app.

Jack said he felt lucky to be treated so quickly thanks in part to this ground-breaking trial.

"I'm grateful my mate called Triple Zero straight away, the paramedics arrived minutes later and were amazing from start to finish," Jack said.

"I was scanned by the Strokefinder helmet and examined on a video call direct to the neurologist at hospital This collaboration and quick response was a major factor in making a full recovery."

Minister for the Hunter Yasmin Catley said regional Australians are 17 percent more likely to suffer a stroke than those in metropolitan areas.

"In the Hunter New England Health District, around 1,500 residents experience a stroke each year, so it makes sense a trial like this would take place here," Ms Catley said.

Member for Wallsend Sonia Hornery said she was proud clinicians from John Hunter Hospital are involved in the trial.

"Some of our best and brightest work at John Hunter Hospital, and for them to be involved this frontline research which is improving outcomes for people suffering a stroke is really fantastic," Ms Hornery said.

NSW Ambulance in partnership with Hunter New England Local Health District, Medfield Diagnostics, Hunter Medical Research Institute, and Titan Neuroscience Research Australia, anticipate reporting trial results later this year.

För mer information kontakta:
Björn Larsson CEO, Medfield Diagnostics AB, tel+46 766 201 725

Medfield Diagnostics har som mål att underlätta diagnostiseringen av stroke och huvudtrauma. Om man på ett tidigt stadium kan avgöra om patienten har en stroke eller inte, skulle behandlingsprocessen kunna påskyndas och rätt behandling sättas in betydligt tidigare än idag. Därigenom kan det elimineras mycket lidande hos drabbade patienter och det skulle kunna sparas mycket stora vård- och rehabiliteringskostnader för samhället.